Cholic Acid Series Products: Pricelist & Exporter to the Russian Federation Market

Industrial Analysis & Market Outlook for Bile Acids in Russia

An authoritative look at the macro-economic and biochemical landscapes of the Cholic Acid Series (CAS 81-25-4) and its derivatives across Eurasia.

1. Global Cholic Acid (CA) Market Dynamics

Cholic acid, along with its primary derivatives such as Chenodeoxycholic Acid (CDCA), Ursodeoxycholic Acid (UDCA), and Deoxycholic Acid (DCA), represents a foundational group of steroidal compounds crucial for modern physiological medicine. Derived primarily from natural bovine or porcine bile extraction, the global supply chains of high-purity bile compounds are constrained by ecological, ethical, and logistics parameters. As pharmaceutical enterprises globally scale up the synthesis of next-generation therapies targeting non-alcoholic steatohepatitis (NASH), primary biliary cholangitis (PBC), and advanced lipid metabolisms, the baseline demand for GMP-grade raw material intermediates continues to experience double-digit compound annual growth (CAGR).

2. The Russian Federation's Pharmaceutical Import Substitution Strategy

Under the framework of Russia's national development roadmap "Pharma 2030" (Фарма-2030), the domestic chemical-pharmaceutical sector is rapidly shifting toward vertical integration. The Russian Ministry of Industry and Trade has prioritized localized synthesis of APIs to diminish dependencies on Western European finished dosage forms. Bile acid derivatives like Ursodeoxycholic acid (Урсодезоксихолевая кислота) are widely prescribed across Russia for gastrointestinal treatment, gallbladder gallstone dissolution, and liver hepatoprotection. Russian pharmaceutical giants require reliable, cost-efficient exporters of high-purity Cholic acid and intermediate derivatives to establish local manufacturing loops. Chengdu Chenlv Herb fulfills this industrial gap by providing bulk shipments compliant with the State Pharmacopoeia of the Russian Federation (ФС.2.2.0016.15 equivalent standards).

3. Key Technical Specifications and Purity Controls

The manufacturing process at Chengdu Chenlv Herb's state-of-the-art facility utilizes advanced industrial chromatography and crystallization technologies. We control the assay parameters tightly:

• Purity (HPLC): ≥ 98.0% min for all standard grades, with options for customized ultra-pure APIs up to 99.5%.
• Heavy Metals (Pb, As, Hg, Cd): ≤ 10 ppm total, complying with EAEU technical regulations on chemical safety.
• Residual Solvents: Strict gas chromatography headspace analysis (GC-HS) ensuring residues of methanol, ethanol, and acetone fall well below ICH Q3C limits.
• Microbial Control: Total aerobic microbial count (TAMC) ≤ 1000 cfu/g, yeasts & molds ≤ 100 cfu/g, and absolutely free of Salmonella and Escherichia coli.

4. Industrial Application Scenarios in Russia

Beyond human pharmaceuticals, the industrial utilization of the Cholic Acid series spans multiple key sectors in Russia:

• Aesthetic Medicine & Lipolysis: Deoxycholic acid formulations (e.g., localized fat-dissolving injections) are observing rapid uptake within cosmetic clinics across Moscow, Saint Petersburg, and Kazan.
• Veterinary Hepatoprotectors: The Russian agro-industrial complex, specifically the intensive poultry and pig farming clusters in Belgorod, Voronezh, and Krasnodar regions, relies heavily on bile acids to optimize feed conversion ratios (FCR) and prevent fatty liver syndrome in livestock.
• Aquaculture Feed Additives: With the expansion of salmonid aquaculture in Karelia and Murmansk, bile acids are introduced into specialized fish feeds to enhance cholesterol absorption, lipid digestibility, and overall growth kinetics.